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ABSTRACT 
International Journal of Exercise Science 13(2): 225-233, 2020. This study examined whether a 
commercially available low-dose (1.2 mg), chewable capsaicin supplement could enhance endurance 
cycling performance. Thirteen young (8M/5F), recreationally active individuals (age = 24.2 ± 2.9 yrs, 
body fat = 21.2 ± 6.1%) participated in the study. The study consisted of three visits, beginning with an 
initial evaluation of cardiorespiratory fitness (37.1 ± 5.5 ml/kg/min). During the second and third study 
visits, participants completed time-to-exhaustion (TTE) tests on a cycle ergometer at a workload eliciting 
~90% VO2max, 45 minutes after ingesting either a 139 kcal capsaicin fruit gummy, or eucaloric placebo. 
Heart rate and rating of perceived exertion (RPE) were recorded every two minutes throughout the TTE 
sessions. Time-to-exhaustion was not significantly different (p > 0.05; d = 0.13) between placebo (487.8 ± 
187.7 sec) and capsaicin (517.5 ± 258.4 sec) trials. Furthermore, heart rate responses and ratings of 
perceived exertion were similar (p > 0.05) between trials. These findings suggest that pre-exercise 
ingestion of a commercially available low-dose (1.2 mg), chewable capsaicin supplement fails to provide 
ergogenic benefits for time-to-exhaustion during cycling exercise. Higher doses may be necessary to elicit 
the performance-enhancing benefits observed during alternative exercise modalities (i.e., running) of 
comparable intensity. 
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INTRODUCTION 
 
Capsaicin (8-methyl-N-vanillyl-trans-6-nonenamide) is a naturally occurring substance found 
primarily in chili peppers that agonizes transient receptor potential vanilloid receptor-1 (TRPV1) 
ion channels throughout the body leading to the sensation of heat (25). Oral ingestion of 
capsaicin is purported to elicit a host of physiological effects including activation of the 
sympathetic nervous system, increased lipid oxidation and energy metabolism (14, 19), 
thermogenesis (16, 18), and activation of anti-inflammatory pathways (15). In skeletal muscle, 
capsaicin interaction with TRPV1 on the sarcoplasmic reticulum is suggested to potentiate 
intracellular calcium release via ryanodine receptor 1 regulation (17), which may have 
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implications for contractile function and thus athletic performance (e.g., increased power output 
during cycling via the quadriceps muscle group). 
 
In mice, acute capsaicin ingestion is demonstrated to improve time-to-exhaustion with running 
and swimming (19, 21, 22) and grip strength (12) in an apparent dose-dependent manner (21). It 
is important to keep in mind that performance-enhancing capsaicin doses in animal models (up 
to 1000 mg/kg body weight) are substantially greater than what may be safely tolerated by 
humans. To date, we were only able to identify four human studies seeking to evaluate the 
performance-enhancing potential of ingested capsaicin (5-7, 23), three of which from the same 
investigative team (5-7). In 2012, Opheim and Rankin demonstrated 7-day capsaicin 
supplementation (25.8 mg/day) provided no appreciable benefits for repeated sprint 
performance, but evoked significant gastrointestinal distress in nearly a quarter of the subjects 
(23). Using a lower capsaicin dose (12 mg 45-min prior to exercise), de Freitas and colleagues 
demonstrated participants were able to perform more repetitions over the course of four squat 
sets to failure (6), improve 1500-m run time (7) and extend time-to-exhaustion during high-
intensity intermittent exercise (i.e., 15-sec sprints:15-sec rest) (5). Given these promising 
findings, examination of the ability for acute capsaicin supplementation to improve exercise 
performance in other domains is enticing. 
 
As capsaicin supplementation to enhance sports performance has only recently entered 
scientific debate, the minimum effective dose that is least likely to elicit gastrointestinal distress 
has yet to be determined. Therefore, the purpose of this study was to investigate the effect of a 
commercially available low-dose capsaicin supplement (1.2 mg) on time to exhaustion during 
cycling, an exercise modality dependent on both cardiovascular and musculoskeletal systems. 
This was the first exercise-related study in which human subjects ingested a chewable form of 
capsaicin, rather than a pill. A central mechanism for increased endurance performance has been 
proposed with carbohydrate mouth rinsing (3), thus, it would be interesting to determine if 
capsaicin-mediated TRPV1 activation in the oropharynx (1) may yield similar performance 
benefits (8). With this in mind, we hypothesized that acute low-dose capsaicin supplementation 
would extend time-to-exhaustion during cycling exercise. 
 
METHODS 
 
Participants 
Based on previous observations (7) of capsaicin-mediated improvements in 1500-m run time (d 
= 1.2), a minimum of ten individuals were required to achieve 80% statistical power at an alpha-
level of 0.05. Thus, we recruited thirteen recreationally active (≥ 30-min self-reported moderate-
vigorous physical activity per day ≥ 3-d per week) college-age (18-30 yrs) males and females. 
Participants with orthopedic or neurologic conditions, or those reporting allergies to any of the 
supplement or placebo ingredients were excluded. This study was approved by the Georgia 
Southern University Institutional Review Board and all subjects provided written consent to 
participate. The study was a single blind, randomized crossover design consisting of three visits, 
as depicted in Figure 1 and described in greater detail below. This research was carried out fully 
in accordance with the ethical standards of the International Journal of Exercise Science (20). 
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Table 1. Participant characteristics (Means ± SD) 
    Age (yrs) Height 
(cm) 
Weight 
(kg) 
BMI 
(kg/m2) 
Body Fat (%) VO2max 
(ml/kg/min) 
Males (n = 8) 25.3 ± 3.1 179.9 ± 3.6 86.5 ± 9.7 27.0 ± 2.6 17.0 ± 3.7 38.4 ± 3.7 
Females (n = 5) 22.3 ± 2.1 162.8 ± 9.0 68.0 ± 8.5 26.2 ± 1.0 27.0 ± 2.7 34.4 ± 6.3 
 
Protocol 
During visit one anthropometrics were obtained and body fat was assessed via bioelectrical 
impedance analysis using an Omron HBF-306CN portable device (Omron Healthcare, Osaka, 
Japan). Maximal oxygen consumption (i.e., VO2max) testing followed a standardized testing 
protocol proven to elicit volitional exhaustion between 8-12 minutes in duration in a similar 
population (9). Criteria for attainment of VO2max included satisfying two of the following: RER 
> 1.1, rating of perceived exertion (RPE) > 17, or achievement of 90% age-predicted maximal 
heart rate (2). All testing was performed on a calibrated cycle ergometer (Monark LC6 Novo, 
Vansbro, Sweden) and seat and handlebar position were adjusted to each participant and 
positions were recorded for standardization among sessions. A minimum of 48 hours was 
required between VO2max and the second study visit. 
 
On the second and third study visits, participants reported to the laboratory where they 
consumed either a 1) spicy fruit gummy (139 kcals) containing 1.2 mg capsaicin (Bollox Ltd, 
Admiralty, Hong Kong) or 2) eucaloric fruit gummy, the order of which was randomized. 
Capsaicin is shown to reach peak plasma concentrations 45 minutes following ingestion (4). 
Thus, prior to TTE testing subjects were given a 45 minute waiting period during which they 
remained in the testing facility and sat quietly. TTE sessions began with a 5-min warm-up using 
50 W for females and 100 W for males after which the load was increased to the pre-determined 
wattage eliciting ~90% of individual VO2max (10). Heart rate was recorded every two minutes 
and participants were asked to pedal until volitional exhaustion or until they were unable to 
sustain a cadence of greater than 60 RPM. RPE was recorded two minutes into the testing session 
but then stopped so as not to interfere with the subject. At the completion of the session, RPE 
was once again queried. Prior to visit departure, subjects were provided with a gastrointestinal 
(GI) distress form, where they were asked to document any GI complaints occurring over the 
next 48 hours. TTE sessions were separated by a minimum of seven days and performed at the 
same time of day to ensure chronobiologic control. During the 24-h period prior to each visit, 
subjects were asked to follow the same diet and avoid spicy food as well as refrain from vigorous 
activity. Subjects were asked to refrain from caffeine the day of exercise testing. 
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Figure 1. Schematic of study design. 
 
Statistical Analysis 
Data was analyzed with the Statistical Package for the Social Sciences (SPSS, Inc., Chicago, IL, 
USA). Independent variables included the capsaicin or placebo conditions, while dependent 
variables were TTE, RPE, and heart rate. Normality of data was confirmed using the Shapiro-
Wilk test, with the exception of heart rate max during capsaicin trials and RPE at test termination 
of placebo trials. Paired t-tests and corresponding effect sizes (Cohen’s d) were run to compare 
time to exhaustion, heart rate response (average and maximum), and RPE values between trials. 
Additionally, paired t-tests with appropriate Bonferroni adjustment were used to evaluate 
potential differences in heart rates between trials at 2, 4, 6, 8 and 10 minutes. Wilcoxon Signed-
Rank tests were used for data that were not normally distributed (heart rate max and RPE at test 
termination). Alpha level was set at <0.05. 
 
RESULTS 
 
Participant Characteristics: Participant characteristics are provided in Table 1 as means ± SD. 
The capsaicin supplement was well-tolerated by all participants, without a single complaint of 
gastrointestinal distress. Cardiorespiratory fitness (i.e., VO2max) values were ~50th percentile 
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for both male and female subjects (2), which confirmed their recreationally active status. Peak 
power outputs achieved during the VO2max test were 240 ± 24 and 172 ± 21 watts for males and 
females, respectively.  
 
Time to Exhaustion: In all trials, average time to exhaustion was 502.62 sec. Time to exhaustion 
at a workload eliciting ~90% VO2max was not significantly different (p = 0.52; d = 0.13) between 
placebo (487.8 ± 187.7 sec) and capsaicin (517.5 ± 258.4 sec) trials (Figure 2). Average cadence 
was not significantly different (p > 0.05) between placebo (69.2 ± 5.6) and capsaicin (68.9 ± 4.8) 
trials. Similar TTE (519.0 ± 240.6 sec vs. 499.8 ± 196.8 sec) and cadence (68.7 ± 4.0 vs. 69.3 ± 5.6) 
values between trials 1 and 2, respectively, confirmed a lack of learning effect. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Means ± SD (bars) and individual data points (lines) for placebo and capsaicin time-to-exhaustion trials. 
 
Heart rate and Rating of Perceived Exertion Measures: Pre-exercise resting heart rate was not 
significantly different (p > 0.05; d = 0.18) 45-min after ingesting either the capsaicin (71.3 ± 8.5 
bpm) or placebo (73.7 ± 16.7 bpm) supplement. Average heart rate did not differ (p = 0.78; d = 
0.13) between placebo (148.3 ± 11.8 bpm) and capsaicin (146.2 ± 8.1 bpm) TTE trials. 
Furthermore, maximal heart rate was also similar (p = 0.90; d = 0.05) between placebo (182.1 ± 
8.7 bpm) and capsaicin (182.5 ± 7.2 bpm) trials. Average heart rate values throughout the time 
to exhaustion sessions in placebo and capsaicin trails were also similar (p > 0.05) at all time 
points (i.e., 2, 4, 6, 8, and 10 min; Figure 3). Participant ratings of perceived exertion (RPE) did 
not differ (p > 0.05) during the warm-up (9.8 ± 1.6 vs. 8.8 ± 1.4; d = 0.65), two minutes into the 
trial (13.4 ± 2.4 vs. 13.3 ± 2.0; d = 0.03), and at session termination (18.6 ± 1.1 vs. 18.6 ± 1.3; d = 
0.0) between placebo and capsaicin trials, respectively. 
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Figure 3. Average heart rate values for placebo (black) and capsaicin (gray) trials at 0 (rest), 2, 4, 6, 8, and 10 minutes 
during time to exhaustion trials (Means ± SD). 
 
DISCUSSION 
 
Contrary to our hypothesis, a commercially available low-dose (1.2 mg), chewable capsaicin 
supplement failed to extend time-to-exhaustion during cycling exercise. The ineffectiveness of 
the administered supplement to influence exercise performance was supported by its inability 
to alter related physiological parameters (i.e., heart rate and/or perceived exertion). This finding 
is in contrast to previous investigations showing improvements in both aerobic (7) and 
anaerobic (5, 6) exercise performance following acute ingestion of a larger-dose (12 mg) 
capsaicin pill, which appeared to moderate subjective strain (i.e., RPE). 
 
To maximize ergogenic potential while minimizing unwanted side-effects, a minimum effective 
dose for pre-exercise capsaicin ingestion should be determined. Gastrointestinal complaints 
have been reported in previous performance-related human studies issuing doses of ~0.3 mg/kg 
body weight (23). However, substantially lower capsaicin doses (0.03 mg/kg body weight) 
ingested with a meal have proven to enhance fat oxidation and energy expenditure in resting 
human subjects (13). The present study utilized a similar capsaicin dose (~0.02 mg/kg body 
weight) in chewable form, based on the postulate that stimulation of oral TRPV1 receptors may 
amplify the physiological response, but no ergogenic effects were observed. Taken together, 
these findings suggest that although lower capsaicin doses may be sufficient to influence resting 
physiology, higher doses may be necessary to significantly alter physiological function and 
influence high-intensity exercise performance. Future studies are encouraged to explore the 
potential for cumulative low-dose capsaicin supplementation as a means to overcome 
undesirable gastrointestinal side effects while maximizing performance benefits. 
 
Contrary to the notion that low-dose capsaicin supplementation may acutely influence resting 
systems physiology, resting heart rate was not affected 45-min after capsaicin ingestion. 
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Furthermore, similar heart rate values between TTE trials (Figure 3) provide continued support 
for a lack of capsaicin-mediated chronotropic influence. Moreover, similar RPE scores at various 
time points in the present study insinuates that the orally administered low capsaicin dose was 
inadequate to alter subjective strain. This finding is in contrast to previous research that used a 
larger capsaicin dose (12 mg) where reduced perceived exertion and improved 1500-m run 
performance were observed (7), portending to a possible sympathetic-mediated increase in pain 
threshold. These conflicting findings bring to light the probable mechanism by which greater 
capsaicin doses may improve exercise performance (i.e., increased tolerance to exertion).  
 
Findings from the present study should be interpreted in the context of a few considerations. 
First, it should be acknowledged that subjects may have been able to differentiate between the 
placebo and capsaicin-containing fruit gummies (both 139 kcals), although we avoided asking 
about this matter in an attempt to mitigate participant performance bias. If an understanding of 
whether capsaicin-mediated activation of oral receptors (2, 24) plays a role in mediating the 
physiological response to capsaicin ingestion is desired, this obstacle is difficult to overcome. It 
is also possible that any performance-enhancing benefits of capsaicin may have been masked by 
the well-known benefits of pre-exercise carbohydrate intake (11). This study was also the first to 
examine the ergogenic potential of capsaicin in a mixed-gender sample, and although no gender 
differences were observed, this could be due to our relatively modest sample size. Finally, it 
should be kept in mind that although participants in our study were recreationally active, most 
were not accustomed to cycling exercise, and thus upstream neuromuscular competencies may 
have limited time-to-exhaustion performance before the intramuscular benefits of capsaicin 
could be realized. 
 
In summary, acute capsaicin ingestion using a commercially available low-dose (1.2 mg), 
chewable supplement did not affect time to exhaustion, heart rate response, or perceived 
exertion during high-intensity cycling exercise. Higher capsaicin doses may be necessary to 
improve cycling performance in recreationally active individuals. However, the effects of this 
low capsaicin dose on metabolic function and/or performance in more familiar exercise modes 
is unknown and deserving of further inquiry. 
 
ACKNOWLEDGEMENTS 
 
The authors have no conflicts of interest to declare and no funding was received for this study. 
We would like to thank our participants for their time and efforts that made this study possible. 
 
REFERENCES 
 
1. Alvarez-Berdugo D, Rofes L, Farre R, Casamitjana JF, Enrique A, Chamizo J, Padron A, Navarro X, Clave P. 
Localization and expression of TRPV1 and TRPA1 in the human oropharynx and larynx. Neurogastroenterol 
Motil 28: 91-100, 2016. 
 
2. American College of Sports Medicine. ACSM’s guidelines for exercise testing and prescription. 10th ed. 
Philadelphia: Wolters Kluwer; 2018. 
Int J Exerc Sci 13(2): 225-233, 2020 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
232 
3. Carter JM, Jeukendrup AE, Jones DA. The effect of carbohydrate mouth rinse on 1-h cycle time trial 
performance. Med Sci Sports Exerc 36: 2107-2111, 2004. 
 
4. Chaiyasit K, Khovidhunkit W, Wittayalertpanya S. Pharmacokinetic and the effect of capsaicin in Capsicum 
frutescens on decreasing plasma glucose level. J Med Assoc Thai 92: 108-113, 2009. 
 
5. de Freitas MC, Billaut F, Panissa VLG, Rossi FE, Figueiredo C, Caperuto EC, Lira FS. Capsaicin 
supplementation increases time to exhaustion in high-intensity intermittent exercise without modifying 
metabolic responses in physically active men. Eur J Appl Physiol 119: 971-979, 2019. 
 
6. de Freitas MC, Cholewa JM, Freire RV, Carmo BA, Bottan J, Bratfich M, Della Bandeira MP, Goncalves DC, 
Caperuto EC, Lira FS, Rossi FE. Acute capsaicin supplementation improves resistance training performance in 
trained men. J Strength Cond Res 32: 2227-2232, 2018. 
 
7. de Freitas MC, Cholewa JM, Gobbo LA, de Oliveira J, Lira FS, Rossi FE. Acute capsaicin supplementation 
improves 1,500-m running time-trial performance and rate of perceived exertion in physically active adults. J 
Strength Cond Res 32: 572-577, 2018. 
 
8. Gibson OR, Wrightson JG, Hayes M. Intermittent sprint performance in the heat is not altered by augmenting 
thermal perception via L-menthol or capsaicin mouth rinses. Eur J Appl Physiol 119: 653-664, 2019. 
 
9. Gries KJ, Raue U, Perkins RK, Lavin KM, Overstreet BS, D'Acquisto LJ, Graham B, Finch WH, Kaminsky LA, 
Trappe TA, Trappe S. Cardiovascular and skeletal muscle health with lifelong exercise. J Appl Physiol (1985) 
125: 1636-1645, 2018. 
 
10. Hagerman F, Hagerman, M. A comparison of energy output and input among elite rowers. FISA Coach (Section 
10): 267-272, 1990. 
 
11. Hargreaves M, Hawley JA, Jeukendrup A. Pre-exercise carbohydrate and fat ingestion: effects on metabolism 
and performance. J Sports Sci 22: 31-38, 2004. 
 
12. Hsu YJ, Huang WC, Chiu CC, Liu YL, Chiu WC, Chiu CH, Chiu YS, Huang CC. Capsaicin supplementation 
reduces physical fatigue and improves exercise performance in mice. Nutrients 8(10): e648, 2016. 
 
13. Janssens PL, Hursel R, Martens EA, Westerterp-Plantenga MS. Acute effects of capsaicin on energy expenditure 
and fat oxidation in negative energy balance. PloS One 8(7): e67786, 2013. 
 
14. Josse AR, Sherriffs SS, Holwerda AM, Andrews R, Staples AW, Phillips SM. Effects of capsinoid ingestion on 
energy expenditure and lipid oxidation at rest and during exercise. Nutr Metab (Lond.) 7: 65, 2010. 
 
15. Kang C, Wang B, Kaliannan K, Wang X, Lang H, Hui S, Huang L, Zhang Y, Zhou M, Chen M, Mi M. Gut 
microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and 
associated obesity induced by high-fat diet. mBio 8(3): e00470-17, 2017. 
 
16. Kim DH, Joo JI, Choi JW, Yun JW. Differential expression of skeletal muscle proteins in high-fat diet-fed rats in 
response to capsaicin feeding. Proteomics 10: 2870-2881, 2010. 
Int J Exerc Sci 13(2): 225-233, 2020 
International Journal of Exercise Science                                                          http://www.intjexersci.com 
233 
17. Lotteau S, Ducreux S, Romestaing C, Legrand C, Van Coppenolle F. Characterization of functional TRPV1 
channels in the sarcoplasmic reticulum of mouse skeletal muscle. PLoS One 8(3): e58673, 2013. 
 
18. Ludy MJ, Moore GE, Mattes RD. The effects of capsaicin and capsiate on energy balance: critical review and 
meta-analyses of studies in humans. Chem Senses 37: 103-121, 2012. 
 
19. Luo Z, Ma L, Zhao Z, He H, Yang D, Feng X, Ma S, Chen X, Zhu T, Cao T, Liu D, Nilius B, Huang Y, Yan Z, 
Zhu Z. TRPV1 activation improves exercise endurance and energy metabolism through PGC-1alpha 
upregulation in mice. Cell Res 22: 551-564, 2012. 
 
20. Navalta JW, Stone WJ, Lyons TS. Ethical issues relating to scientific discovery in exercise science. Int J Exerc Sci 
12: 1-8, 2019. 
 
21. Oh TW, Oh TW, Ohta F. Dose-dependent effect of capsaicin on endurance capacity in rats. Br J Nutr 90: 515-
520, 2003. 
 
22. Oh TW, Ohta F. Capsaicin increases endurance capacity and spares tissue glycogen through lipolytic function 
in swimming rats. J Nutr Sci Vitaminol (Tokyo) 49: 107-111, 2003. 
 
23. Opheim MN, Rankin JW. Effect of capsaicin supplementation on repeated sprinting performance. J Strength 
Cond Res 26: 319-326, 2012. 
 
24. Smutzer G, Jacob JC, Tran JT, Shah DI, Gambhir S, Devassy RK, Tran EB, Hoang BT, McCune JF. Detection and 
modulation of capsaicin perception in the human oral cavity. Physiol Behav 194: 120-131, 2018. 
 
25. Yang F, Zheng J. Understand spiciness: mechanism of TRPV1 channel activation by capsaicin. Protein Cell 8: 
169-177, 2017. 
 
